| Theme | Advanced Therapy Ulcerative Colitis | |
|---|---|---|
| Title | Treatment and Follow-up of Mild Ulcerative Colitis | |
| Publish Date | 1997/09 | |
| Author | Hideyuki Kishi | Third Department of Internal Medicine |
| Author | Sumio Fujinuma | Third Department of Internal Medicine |
| [ Summary ] | Therapy for ulcerative colitis is selected on the basis of clinical severity. Mild cases are treated mainly with salicylazosulfapyridine and mesalazine. If there is no response, patients with proctitis-type disease are concomitantly given betamethasone suppositories and those with left-sided colonic involvement are given prednisolone enema therapy. Even after remission, patients should be carefully observed. A good patient-physician relationship, continuation of maintenance therapy, and periodic follow-up examinations are essential to successful long-term management of this disease. Regardless of clinical severity, patients with mild ulcerative colitis who have repeated flare-ups should receive the next therapeutic step, if indicated by endoscopic findings and clinical course. |
|